What is the recommended dosage of rabies immunoglobulin (RIG) for post-exposure prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabies Immunoglobulin Dosage

The recommended dose of rabies immunoglobulin (RIG) for post-exposure prophylaxis is exactly 20 IU/kg body weight, administered once at the beginning of treatment, with the full calculated dose infiltrated around and into all wounds if anatomically feasible. 1, 2, 3

Standard Dosing Protocol

  • Administer 20 IU/kg body weight as a single dose - this applies universally to all age groups including children, and is the standard for both human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). 1, 2, 3

  • Never exceed the recommended 20 IU/kg dose, as higher doses can partially suppress active antibody production from the vaccine, potentially compromising protection. 1, 2, 4, 3

  • The 20 IU/kg dosing was established through clinical trials that demonstrated 40 IU/kg interfered with optimal vaccine-induced antibody production, while 20 IU/kg provided adequate passive immunity without significant interference. 5

Timing of Administration

  • RIG should ideally be given simultaneously with the first vaccine dose on day 0 to provide immediate passive immunity while the body begins producing its own antibodies. 2, 4, 3

  • If not given on day 0, RIG can still be administered up to and including day 7 of the vaccine series. 2, 4, 3

  • Beyond day 7, do not administer RIG because an antibody response to the vaccine is presumed to have occurred by that time, making passive immunization unnecessary. 2, 4

Administration Technique

  • Infiltrate the full calculated dose thoroughly in the area around and into all wounds if anatomically feasible - this is critical because rare failures of post-exposure prophylaxis have been reported when less than the full amount was infiltrated at exposure sites. 1, 2, 3

  • Any remaining volume after wound infiltration should be administered intramuscularly at a site distant from vaccine administration (typically the deltoid muscle or lateral thigh, never the gluteal region). 1, 2, 3

  • Never administer RIG in the same syringe, needle, or anatomical site as the vaccine because this may interfere with vaccine immunogenicity. 1, 2, 4, 3

Critical Contraindications

  • Do not give RIG to previously vaccinated persons - individuals with a documented history of complete pre-exposure or post-exposure vaccination with cell culture vaccines require only a 2-dose vaccine booster (days 0 and 3) without RIG, as the immunoglobulin will inhibit their anamnestic antibody response. 1, 2, 4, 3

Vaccine Schedule Considerations

  • For previously unvaccinated immunocompetent persons, RIG is combined with a 4-dose vaccine schedule on days 0,3,7, and 14. 1, 2, 4

  • For immunocompromised patients, use a 5-dose vaccine schedule on days 0,3,7,14, and 28 along with the standard 20 IU/kg RIG dose. 1, 2, 4

Common Pitfalls to Avoid

  • Avoid the gluteal region for any injections (both RIG and vaccine) due to risk of sciatic nerve injury and inadequate antibody response. 4, 3

  • Do not use abbreviated vaccine schedules (such as the 2-1-1 regimen) when RIG is administered - studies demonstrate that RIG suppresses vaccine immunogenicity with these shortened schedules, with HRIG showing more pronounced suppression than ERIG, resulting in suboptimal seroconversion rates. 6, 7

  • Calculate the exact dose based on current body weight - underdosing may provide inadequate passive protection, while overdosing suppresses active antibody production. 1, 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.